Literature DB >> 28100471

Valve thrombosis following transcatheter aortic valve replacement: significance of blood stasis on the leaflets.

Koohyar Vahidkhah1, Mohammed Barakat1, Mostafa Abbasi1, Shahnaz Javani1, Peyman N Azadani2, Anwar Tandar2, Danny Dvir3, Ali N Azadani1.   

Abstract

OBJECTIVES: Leaflet thrombosis following transcatheter aortic valve replacement (TAVR) and valve-in-valve (ViV) procedures has been increasingly recognized. However, the factors affecting the post-TAVR/ViV thrombosis are not fully understood. This study aimed to investigate the effect of the geometric confinement of transcatheter aortic valve (TAV) on blood residence time (BRT) on the TAV leaflets and in turn on the post-TAVR valve thrombosis.
METHODS: Two computational models, representing a surgical bioprosthesis and a TAV, were developed to study the effect of the geometric confinement on BRT on the leaflets in ViV setting/TAVR Intra-annular positioning. 3D flow fields were obtained via a one-way fluid-solid interaction modelling approach validated by experimental testing. BRT was compared between the two models by quantification and statistical analysis of the residence time of randomly distributed particles in close proximity of the leaflets.
RESULTS: Significantly longer BRT on the leaflets was observed in the TAV compared to the surgical valve during different stages of the cardiac cycle. During forward flow, the mean value of BRT was found to be 39% higher in the TAV compared to the surgical bioprosthesis ( P <  0.0001). During diastole, specifically from end-systole to mid-diastole and from mid-diastole to the beginning of systole, the amount by which the mean BRT was higher for TAV compared to the surgical valve was 150% and 40%, respectively ( P <  0.0005).
CONCLUSIONS: The geometric confinement of TAV by the failed bioprosthesis or the calcified native valve increases the BRT on the TAV leaflets. This may act as a permissive factor in valve thrombosis.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Blood residence time; Thrombosis ; Transcatheter heart valve replacement ; Valve-in-valve

Mesh:

Year:  2017        PMID: 28100471     DOI: 10.1093/ejcts/ezw407

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  Three-dimensional extent of flow stagnation in transcatheter heart valves.

Authors:  Vrishank Raghav; Chris Clifford; Prem Midha; Ikechukwu Okafor; Brian Thurow; Ajit Yoganathan
Journal:  J R Soc Interface       Date:  2019-05-31       Impact factor: 4.118

2.  In-Vitro Assessment of the Effects of Transcatheter Aortic Valve Leaflet Design on Neo-Sinus Geometry and Flow.

Authors:  Beatrice Ncho; Vahid Sadri; Jillian Ortner; Sai Kollapaneni; Ajit Yoganathan
Journal:  Ann Biomed Eng       Date:  2020-10-23       Impact factor: 3.934

3.  The role of antiplatelet drug resistance in subclinical leaflet thrombosis following transcatheter aortic valve replacement.

Authors:  Hashrul N Rashid; Paul Thein; Arthur Nasis
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

Review 4.  Principles of TAVR valve design, modelling, and testing.

Authors:  Oren M Rotman; Matteo Bianchi; Ram P Ghosh; Brandon Kovarovic; Danny Bluestein
Journal:  Expert Rev Med Devices       Date:  2018-10-29       Impact factor: 3.166

5.  Impact of Leaflet Laceration on Transcatheter Aortic Valve-in-Valve Washout: BASILICA to Solve Neosinus and Sinus Stasis.

Authors:  Hoda Hatoum; Pablo Maureira; Scott Lilly; Lakshmi Prasad Dasi
Journal:  JACC Cardiovasc Interv       Date:  2019-07-08       Impact factor: 11.195

6.  Subclinical Leaflet Thrombosis in Supra-annular Transcatheter Aortic Valves: the Role of Leaflet Design.

Authors:  Dong Qiu; Ali N Azadani
Journal:  J Cardiovasc Transl Res       Date:  2022-10-19       Impact factor: 3.216

7.  Patient-Specific Immersed Finite Element-Difference Model of Transcatheter Aortic Valve Replacement.

Authors:  Jordan A Brown; Jae H Lee; Margaret Anne Smith; David R Wells; Aaron Barrett; Charles Puelz; John P Vavalle; Boyce E Griffith
Journal:  Ann Biomed Eng       Date:  2022-10-20       Impact factor: 4.219

8.  Clinical predictors and sequelae of computed tomography defined leaflet thrombosis following transcatheter aortic valve replacement at medium-term follow-up.

Authors:  Hashrul N Rashid; Michael Michail; Abdul R Ihdayhid; Cameron Dowling; Nancy Khav; Sean Tan; Jaineel Ramnarain; James D Cameron; Arthur Nasis; Stephen J Nicholls; Robert P Gooley
Journal:  Heart Vessels       Date:  2021-03-04       Impact factor: 2.037

9.  In Vitro Durability and Stability Testing of a Novel Polymeric Transcatheter Aortic Valve.

Authors:  Oren M Rotman; Brandon Kovarovic; Matteo Bianchi; Marvin J Slepian; Danny Bluestein
Journal:  ASAIO J       Date:  2020-02       Impact factor: 3.826

10.  Numerical models for assessing the risk of leaflet thrombosis post-transcatheter aortic valve-in-valve implantation.

Authors:  Romina Plitman Mayo; Halit Yaakobovich; Ariel Finkelstein; Shawn C Shadden; Gil Marom
Journal:  R Soc Open Sci       Date:  2020-12-23       Impact factor: 2.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.